TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biopharmacon, AB
Closing information (x1000 DKK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
315
|
241
|
169 |
Financial expenses |
3
|
0
|
42 |
Earnings before taxes |
148
|
13
|
1,430 |
EBITDA |
41
|
-22
|
11 |
Total assets |
4,645
|
4,299
|
4,730 |
Current assets |
4,372
|
4,033
|
4,436 |
Current liabilities |
109
|
54
|
47 |
Equity capital |
4,481
|
4,200
|
4,623 |
- share capital |
66
|
63
|
70 |
Employees (average) |
1
![]() |
1
![]() |
1 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
96.5%
|
97.7%
![]() |
97.7% |
Turnover per employee |
315
|
241
|
169 |
Profit as a percentage of turnover |
47.0%
|
5.4%
|
846.2% |
Return on assets (ROA) |
3.3%
|
0.3%
|
31.1% |
Current ratio |
4011.0%
|
7468.5%
|
9438.3% |
Return on equity (ROE) |
3.3%
|
0.3%
|
30.9% |
Change turnover |
64
|
88
|
-117 |
Change turnover % |
26%
|
57%
|
-41% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.